BioInvent Announces Board of Directors Update

LUND, SE / ACCESS Newswire / September 2, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced that Vincent Ossipow has stepped down from the Company’s Board of Directors, effective today. The Board wishes to express […]

SAP Deepens European Cloud Sovereignty Offering to Unlock Regional AI Innovation

Decades of SAP's experience in securing mission-critical operations now powers the demands of sovereignty, regulation, and AI-driven growth SAP SE (NYSE: SAP) today announced a comprehensive new approach to digital sovereignty and AI innovation. Expanded offerings within the SAP Sovereign Cloud portfolio give European customers access to a comprehensive technology stack, including SAP Cloud Infrastructure

Hemex expands Global Clinical Network Alliance to strengthen end-to-end CRO Capabilities

A newly established global alliance integrating specialized expertise in oncology, medical imaging, patient recruitment as well as pharmacokinetics and pharmacodynamics studies Comprehensive access to international trial networks, region-specific expertise, and diverse patient populations Supported by a team of over 130 experienced professionals and a Quality Assurance team with a demonstrated history of successful inspections by

Hemex expands Global Clinical Network Alliance to strengthen end-to-end CRO Capabilities

Hemex expands Global Clinical Network Alliance to strengthen end-to-end CRO Capabilities GlobeNewswire September 02, 2025 A newly established global alliance integrating specialized expertise in oncology, medical imaging, patient recruitment as well as pharmacokinetics and pharmacodynamics studies Comprehensive access to international trial networks, region-specific expertise, and diverse patient populations Supported by a team of over 130

The 2025 Kaohsiung Food Show: Asia-Pacific’s Premier Gateway to Food & Beverage Innovation

The 2025Kaohsiung Food Show will return to the Kaohsiung Exhibition Center from October 23-26, 2025. Running concurrently with the Kaohsiung International Hotel, Restaurant, Baking and Catering Show (Kaohsiung HORECA), the event will transform Southern Taiwan into a dynamic hub for the food and hospitality industries in the Asia-Pacific region. https://mma.prnewswire.com/media/2762096/v3.jpg This year's exhibition brings together

Beijing Review: Learning From History to Build a Peaceful Future

This year, we observe the 80th anniversary of the victory in the Chinese People's War of Resistance Against Japanese Aggression–a pivotal part of the World Anti-Fascist War. China's contribution to the Allied victory was bolstered by extensive international support.As we commemorate this milestone in 2025, we are called to remember history, honor the heroes who

Investor Alert: Deadline Approaching to Join Fiserv, Inc. (FI) Class Action – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / September 2, 2025 / If you suffered a loss on your Fiserv, Inc. (NYSE:FI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission-form?prid=164699&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy

Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against durvalumab (PD-L1) combination therapy, for the first-line treatment of advanced biliary tract cancer (BTC) (AK112-309/HARMONi-GI1). This Phase III trial is being conducted in China. Ivonescimab has previously shown

Uranium Energy Corp Launches United States Uranium Refining & Conversion Corp to Advance American Nuclear Fuel Security and Energy Dominance

NYSE American:UEC Uranium Energy Corp (NYSE American: UEC) (the “Company” or “UEC”) is pleased to announce the launch ofUnited States Uranium Refining & Conversion Corp. (“UR&C”), a wholly owned subsidiary of the Company, to pursue the feasibility of developing a new state-of-the-artAmerican uranium refining and conversion facility. Amir Adnani, UEC President and CEO, stated: “Positioning

IBG Business Announces Recent Completed Transactions Demonstrating Robust Activity in the M&A Market

Today,IBG Business, a national, award-winning M&A and business sales firm, announces the successful completion of several recent business ownership transactions. These deals reflect the company's ongoing commitment to help business owners in valuing and selling their companies at the optimum time, for maximum value. https://mma.prnewswire.com/media/2761935/IBG_Business.jpg Recent Completed Transactions: — Deal 1: IBG represented Peerless Tyre

Scroll to Top